Results 281 to 290 of about 935,849 (402)

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Double Blind Controlled Study of Miroprofen in Acute Upper Respiratory Tract Infections

open access: bronze, 1982
Masataka Katsu   +20 more
openalex   +2 more sources

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Factors Associated with Antibiotic Misuse in Outpatient Treatment for Upper Respiratory Tract Infections

open access: yesAntimicrobial Agents and Chemotherapy, 2015
Jennifer L Schroeck   +5 more
semanticscholar   +1 more source

Nasal colonization and lower respiratory tract infections with methicillin-resistant Staphylococcus aureus.

open access: yesAmerican Journal of Critical Care, 2015
Belen Tilahun   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy